Reason for request
Renewal of inclusion
Clinical Benefit
| Substantial |
The Committee considers that the actual benefit of ALTIM remains substantial in rheumatological diseases : - In intra-articular injection: inflammatory arthritis, advanced osteoarthritis. - In periarticular injection: tendinitis, bursitis. - In injection of soft tissue: talalgia, carpal tunnel syndrome, Dupuytren's contracture. |
| Unspecified |
The Committee does not make any comment on the actual benefit of ALTIM in the epidural injection indication : radiculalgia, pending the re-assessment of ALTIM 3.75 mg/1.5 ml suspension for injection an d HYDROCORTANCYL 2.5 % suspension for injection in this single indication. |
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
6RJTTXUeHwfadXer
